Key Takeaways
- Margin expansion leads the story: EBITDA margin jumped to 13.8% from 11.4% QoQ, driven by volume growth of 6.3% and sharply higher utilization across Nigeria, Mexico and Aseptic Packaging.
- Nigeria and Mexico hit near-full throttle: Nigeria reached its highest-ever 90% utilization on currency stabilization, while Mexico hit 98%; both are guided to 100% for all of FY26.
- Three new facilities promise a step-change in scale: PET chips (Egypt), Aseptic (Sanand) and CPP (Mexico) are expected to add INR2,200–2,500 crores annually at full capacity, with partial contribution in FY26 and full potential in FY27.
- BOPP overcapacity is the one clear cloud: Four new capacities arriving from Q1 FY26 will test industry pricing discipline; management expects the impact to be "much lesser pain than BOPET times" but it remains the stated caveat to sustained profitability.[23–24]
- What to watch next quarter: Whether the BOPP capacity additions actually begin to pressure prices, the pace of ramp-up at the three new facilities, and any concrete steps on the value-creation or overseas listing initiative.
Utilization Turnaround: Nigeria, Mexico and Aseptic
- Nigeria transformed: Plant utilization hit 90%, the highest ever, up from 64% in Q2, after an 8% currency appreciation versus September stabilized demand and improved cash flow and receivables planning. Management expects to operate at 100% going forward and for the whole of FY26.
- Mexico near ceiling: Capacity utilization reached 98% versus 85% in Q2, with 100% guided for FY26. The WPP bags investment targets a nearshoring gap: the U.S. imports 80% of its PET food bags globally but sources nothing from next-door Mexico.
- Aseptic Packaging running hot: India capacity utilization hit 104% in the seasonally leanest quarter, up from 84% last year, a 20-percentage-point gain. The expansion from 700 crore to 1,200 crore packs has reached mechanical completion and is moving toward commercial operations.
- Poland the persistent soft spot: Utilization fell back to 61% from 68% in Q2 as European demand stayed weak; India has increased exports to Europe to compensate. Management will try to reach about 80% in FY26.
- Egypt a one-off dip: Technical issues and routine maintenance pulled utilization down; guided to remain at 90%-plus for FY26.
Bhatia: "So, we saw the plant utilization for that improving to 90% in this quarter, which is the highest ever we've achieved so far."
New Capacity: The FY26–FY27 Revenue Bridge
- Three facilities, INR2,200–2,500 crores annual potential: The PET chips facility in Egypt (216,000 MTPA), the Aseptic expansion in Sanand, and the CPP line in Mexico are all expected to add that combined revenue at full utilization. FY26 will see partial contribution; FY27 should capture the full run-rate.
- Egypt PET chips mechanically complete: The 216,000 MTPA plant has achieved mechanical completion and steps are being taken to make it operational; it gives additional volumes starting in Q4.
- Egypt Aseptic expansion underway: About \$19 million was spent during Q3 on the \$126 million project; completion is expected in FY26 with operations from FY27, planned directly for 1,200 crore units.
- India Aseptic target raised: With the upgrade to 1,200 crore packs, management is targeting 1,050–1,100 crore packs for FY26.
- WPP bags ramp-up will be slow: Customer validation means it will take about a couple of years to scale; the \$50 million Mexico investment targets both North and South America.
- Recycling facility in Noida: A new PET bottle, polyethylene and multi-layered plastic recycling plant is being set up at a cost of about INR317 crores, timed to the government mandate of 30% recycled content in rigid plastics and 10% in flexibles from 1 April 2025.
Bhatia: "U.S. imports about 80% of its PET food bags, packaging from all over the world. But there is no nearshoring. So, there is nothing which is being supplied by Mexico, which is next door to this. So that is where we spotted this opportunity."
BOPET and BOPP: One Healed, One at Risk
- BOPET near balance: Overcapacity that plagued the industry has eased because exports from India increased sharply after mid-June, domestic demand rose about 10%, and higher exports reduced domestic availability. Capacity utilization in India moved from 73% to 77%. The pain on the PET side "seems to be over."
- BOPP balanced for now, but four new capacities loom: The market is quite balanced with no significant overcapacity today, but four new capacities will come on stream from June FY26 onward. Management expects some impact on BOPP prices that may last a couple of quarters.
- Industry discipline is the hedge: A price war started in PET but "everybody realized it doesn't help"; overall discipline and export orientation by all players stabilized PET prices. Management hopes similar behavior on the BOPP side means "much lesser pain than what was seen at the BOPET times."
- BOPP overcapacity is the stated caveat to profit consistency: The current quarter's PBT level of INR147 crores consolidated is "100% achievable" going forward, with one exception: expected BOPP overcapacity from Q1 FY26. This is primarily an India problem, not applicable to Hungary or Egypt. [23–24]
- Margins currently stable: BOPP and BOPET margins are at the same level as before, with no upward or downward trend indicated.
Bhatia: "There has been an overall discipline and there has been export orientation by all the players, which has helped stabilize the prices on the PET side. So maybe if similar things happen on the BOPP side also, I think we see the much lesser pain than what was seen at the BOPET times."
Flexible Packaging: Margin-Rich Niche Over Volume
- No capacity expansion in seven years: The flexible packaging business has not grown capacity because industry margins are "not up to the desired level." Only balancing equipment has been added; the strategy is to improve the product mix toward higher-margin retort pouches and away from lower-margin roll form business.
- Integrated model provides an edge: Management stated Uflex is "clearly much better" than standalone competitors like Huhtamaki (5.3% margin) because of its integrated play: own films, packaging, cylinders, chemicals and inks. However, a separate margin figure for the segment was declined.
- Unorganized competition distorts Indian pricing: MNCs in India buy at the cheapest cost rather than from quality suppliers, using small unorganized players (father-son shops not complying with labor laws or directives) to drag down prices for compliant suppliers like Uflex. This dynamic is unique to India and not seen in mature jurisdictions. [26–27]
- Value-added films regain focus: Base films were prioritized during COVID when raw material shortages made everything sellable. Post-normalization in 2023–24, the company has started emphasizing value-added products, though base films remain necessary as a substrate.
Bhatia: "If you compare me with a person who is father and son who are operating the plant at a floor shop level basis and all that not comply to labor guidelines, do not comply to any directives or when I do all that, and I'm subjected to audit also from these setups vis-a-vis. So, they show me that this person is able to give them at a lower cost than me and I should match its price. That cannot be achieved, sir." [26–27]
Recycling: Regulatory Trigger, Cautious Build-Out
- Mandate creates the market: The government mandate of 30% recycled material in rigid plastics and 10% in flexibles from 1 April 2025 is the catalyst. Management noted that as of late February, no relaxation had been given, so the assumption is it will happen, with testing done for the year as a whole.
- Voluntary demand is absent: Nobody wants to pay extra for recycled material without a legal requirement; big brands will comply only under compulsion of law. Companies do not put money on the table voluntarily for recycled content.
- Small pilot plants, not large bets: Uflex has not made large investments because there was no regulation; it has kept up to date with smaller pilot plants to test waters, test efficiencies and test technology. The head start gives an advantage over competition.
- New Noida recycling facility in progress: The INR317 crore plant covering PET bottles, polyethylene and multi-layered plastic is being installed. Management expects recycling will "definitely" offer scope to increase margins because not many players will be able to do it.
- Ramp-up will be gradual: Initial months will see limited material availability; it will take time for things to mature. Present customer requirements may be met with existing capacities to the extent possible.
Bhatia: "I think if we invest in -- we need to invest in this because ultimately, our customer will need a blended material, and we need to be prepared ourselves today for achieving that."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Nigeria utilization | Operate at 100% capacity | Full FY26 |
| Mexico utilization | Operate at 100% capacity | Full FY26 |
| Poland utilization | Achieve about 80% | FY26 |
| Egypt utilization | Remain at 90%-plus | FY26 |
| India Asepto volume | 1,050–1,100 crore packs | FY26 |
| Consolidated revenue growth | 12% to 15% over FY25 | FY26 |
| FY25 EBITDA | About INR2,000 crores | FY25 |
| FY26 EBITDA margin | Around 14% | FY26 |
| New facilities revenue add | INR2,200–2,500 crores annually at full capacity; partial in FY26, full in FY27 | FY26–FY27 |
| Egypt Aseptic expansion | Complete construction; operations from FY27 | FY26 completion |
| Renewable power across plants | 70–80% from renewables | Next two years |
| Net debt | INR1,700 crores capex spend with INR2,000 crores expected repayment; net debt level should not increase | Next two years |
| Consolidated PBT sustainability | Current-quarter level "100% achievable" going forward, barring BOPP overcapacity impact from Q1 FY26 | Ongoing from Q3 FY25 [23–24] |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Revenue | ₹3,774 cr, +12.8% YoY |
| Volume growth | 6.3% YoY |
| EBITDA margin | 13.8%, vs 11.4% in Q2 FY25 |
| 9-month EBITDA margin | 12.6%, +1.1 ppt YoY |
| PAT | ₹111 cr, positive after 4 quarters; aided by ~₹26 cr positive currency impact in Nigeria |
| PBT before exceptional item (consolidated) | ₹147 cr |
| Net debt to EBITDA ratio | 3.24x |
| Consolidated net debt | ₹6,150 cr |
| India net debt | ₹2,650 cr |
| Aseptic Packaging capacity utilization | 104%, vs 84% in Q3 FY24 |
| Nigeria plant capacity utilization | 90%, highest ever; vs 64% in Q2 FY25 |
| Mexico plant capacity utilization | 98%, vs 85% in Q2 FY25 |
| Poland plant capacity utilization | 61%, vs 68% in Q2 FY25 and 61.5% in Q3 FY24 |
| India BOPET capacity utilization | 77%, vs 73% in Q3 FY24 |
| Recycling business capacity utilization | 65% |
| FY26 revenue guidance | 12% to 15% growth over FY25 (consolidated) |
| FY25 EBITDA guidance | ~₹2,000 cr, with ₹1,425 cr achieved in 9M FY25 |
| FY26 EBITDA margin guidance | ~14% |
| Asepto volume target for FY26 | 1,050 cr to 1,100 cr packs |
| Revenue addition from 3 new facilities at full utilization | ₹2,200 cr to ₹2,500 cr annually |
| WPP bags investment in Mexico | \$50 million, targeting 22% to 25% EBITDA margin |
| Recycling facility capex (Noida) | ₹317 cr |
| 9M FY25 capex spent | ~₹1,100 cr, with net debt increase of ~₹550 cr |
| BOPP share of consolidated capacity | ~24% (1,50,000 tons out of 6,20,000 tons) |
| BOPET exports from India growth (last 2 years) | 52% increase |